Save your Skin Foundation webinars are a great way to stay updated by listening to patients, survivors, doctors, and pharmaceutical company executives discuss the melanoma, non-melanoma skin cancer, and ocular melanoma landscape. Each Webinar features a variety of experts and discusses a different topic.  Below is information on upcoming webinars, and links to audio recordings of past webinars.

Webinars 

Recorded June 21 & 22, 2023

Precision medicines are guided by a tumor’s biomarker status and represent a tremendous advancement in cancer treatment. They offer new hope, but systemic barriers to accessing biomarker testing and results need to be addressed. CCRAN’s 2023 Conference focused not only on biomarker testing, but also on the utility of CGP and ctDNA testing to improve patient outcomes in Canada.

Watch the recordings of the 2 day conference here.
Recorded April 15 & 16, 2023

The Symposium was brought to you by Ocumel Canada & featured four key presenters. It consisted of 7 virtual sessions over 2 days and provided up-to-date information on primary and metastatic disease, treatment options, testing, and the psychosocial experience of patients. Patients living with primary and metastatic ocular melanoma also shared their experiences.

Watch a recording of the Day 1 of the Symposium here.
Watch a recording of the Day 2 of the Symposium here.
Recorded March 1, 2023

Presented by Dr. Michael Smylie, Cross Cancer Institute, Edmonton, this webinar reviews breaking news, key takeaways, clinical data and other updates presented at the Canadian Melanoma Conference (CMC) that took place in Banff, Alberta, from February 23-25, 2023. Dr. Smylie presents key clinical trial data from 2022 in the management of melanoma, the latest strategies in melanoma as they pertain to medical oncology, pathology, radiation and surgery, and implementation approaches that maximize the patient standard of care in melanoma. Dr. Michael Smylie is a medical oncologist at the Cross Cancer Institute, and a professor at the Department of Oncology at the University of Alberta in Edmonton

Watch a recording of the webinar here.
Recorded November 23, 2022

This webinar focuses on the experience of cancer survivors and the importance of mental wellness from the perspective of four women with unique backgrounds and experiences in the cancer space. Shannon Gaudette, a melanoma stage 4 survivor, talks about her physical and emotional wellbeing throughout her cancer experience. She is followed by Antonella Scali, Executive Director of the Canadian Psoriasis Network and the daughter of a cancer survivor, who talks about the results of a survey completed by All.Can Canada and implications for mental health and the need for psychosocial supports. Then, Kathy Barnard, president of the Save Your Skin Foundation and a melanoma stage 4 survivor, talks about her experience as a long-time survivor. Finally, Lyanne Westie, SYSF wellness support consultant, presents on the importance of mental wellness in all aspects of life. These short presentations are followed by a discussion between the four presenters, with time for questions from webinar attendees.

Listen to a recording of the webinar here.
Recorded September 14, 2022

This webinar helps patients understand prognostic testing when diagnosed with Ocular Melanoma. It also discusses options for health care professionals for prognostic testing, what it can mean to patients and how it can affect treatment decisions.

Presenters:

Katherina Alsina, PhD, Castle BioSciences

Dr. Marcus Butler, Medical Oncologist, Princess Margaret Cancer Centre

Listen to a recording of the presentation here

Latest news on melanoma/skin cancer/ocular melanoma from ASCO 2022

Recorded June 14, 2022

This webinar reviews late breaking news, key takeaways, clinical data and other updates presented at the American Society of Clinical Oncology (ASCO) Annual Meeting from Chicago, Illinois, in June 2022.

Dr. Marcus Butler, from Princess Margaret Cancer Centre, shares his key insights into what the landscape of melanoma, non-melanoma skin cancers, and ocular melanoma treatment looks like for the near future in Canada.

Listen to a recording of the presentation here

Skin Cancer and Hair Professionals: Learn How You Can Help Save Lives

Recorded April 11, 2022

In this 35 minute webinar, hair professionals will learn about a new initiative called Sty-Lives (Styling Hair and Saving Lives) which aims to train hair professionals to detect potential skin cancers on their clients’ face, ears and scalp. The webinar will go over how to detect potential skin cancers, why hair professionals are uniquely positioned to do this important work and why it is so important. Learn more and register for the program here: https://saveyourskin.ca/sty-lives/

Listen to a recording of the presentation here

Diagnosed with Skin Cancer? Here’s What To Do Next

Recorded February 24, 2022

An Hour with Kathy Barnard

In this webinar, Kathy Barnard, founder of SYSF and melanoma survivor, shares her experience navigating and advocating through the Canadian health care system, which is complicated and can be confusing to many. She helps patients and caregivers understand how to get from diagnosis to surgical and/or systemic treatment of melanoma or non-melanoma skin cancer (NMSC) such as metastatic basal cell carcinoma (BCC), squamous cell carcinoma (SCC) or merkel cell carcinoma (MCC).

Missed the webinar? Listen to a recording of the presentation here
Click here to download to view/print the webinar handout: Questions to Ask Your Doctor

The Future Of Healthcare – Just Because We Can, Doesn’t Always Mean We Should

Recorded November 24, 2021

At Save Your Skin Foundation, we are an organization dedicated to reducing skin cancers in Canada and providing compassionate support to those living with skin cancer. And we are always on the lookout for ways that can help with that mandate, but we also acknowledge we are not the experts on advanced technology.

As part of Digital Health Week 2021 and the #StopWaiting and Get Skin Help campaign, with the folks at Skinopathy, we hosted this roundtable that will help us understand how healthcare is changing due to new technologies, and what needs to happen to keep patients safe. Healthcare and technology luminaries discuss how modern technology and social trends are changing healthcare, but are they all good things and what can be done to safeguard patients?
Moderated by Dr. Jonathan Reichental, with Guests – Ashley Casovan, Pirth Singh, and Keith Loo.

Click here to view the Roundtable Discussion

Post-ASCO 2021 Update with Dr. Hamid: Melanoma, Non-Melanoma Skin Cancers, and Ocular Melanoma

Recorded June 15, 2021

Presented by Dr. Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, California, this webinar  reviews late breaking news, key takeaways, clinical data and other updates presented at the American Society of Clinical Oncology (ASCO) Annual Meeting that took place in a virtual format in June 2021.  Dr. Hamid shares his key insights into what the landscape of melanoma, non-melanoma skin cancers, and ocular melanoma treatment looks like for the near future.

Missed the webinar? Listen to a recording of the presentation here

Melanoma & Non-Melanoma Skin Cancers From A-Z

Recorded May 13, 2021

With Dermatologist Thomas G. Salopek, MD FRCPC, Professor, Department of Medicine, Division of Dermatology, University of Alberta.  This webinar helps educate the general public about the dangers of UV exposure, and it also addresses what options patients and their families have if they are diagnosed with any form of skin cancer. Learn about skin cancer statistics in Canada, sun protection and safety, and details on treatment for primary and metastatic basal cell carcinoma, squamous cell carcinoma, merkel cell carcinoma, and melanoma and melanoma sub-types. For more detailed information on immunotherapy and targeted therapy for each of these please view our webinars further down this page.  This webinar presentation is in collaboration with Save Your Skin Foundation, La Roche-Posay, the Quebec Cancer Foundation, and the Alberta Society of Melanoma.

Missed the webinar? Listen to a recording of the presentation here

Post-ESMO Webinar with Dr. Reinhard Dummer

Recorded October 16, 2020

Presented by Professor Reinhard Dummer, Professor of the University of Zurich and Vice-Chairman of the Department of Dermatology in the University Hospital of Zürich, Switzerland, this webinar reviews late breaking news, key takeaways, clinical data and other updates presented at the European Society for Medical Oncology (ESMO) Virtual Congress Annual Meeting September-October 2020. Dr. Dummer shares his key insights into what the landscape of melanoma and non-melanoma skin cancer treatment looks like for the near future. Watch until the end to see Dr. Dummer and Kathy Barnard discuss hope and survivorship in melanoma skin cancer.

Missed the webinar? Listen to a recording of the presentation here

Basal Cell Carcinoma: What Patients Need to Know

Tuesday, September 29, 2020  –  4pm EDT / 1pm PDT

Dr. Max Sauder, Onco-dermatologist at Princess Margaret Cancer Centre, reviews the latest news, clinical data and other updates as they relate to the treatment of cutaneous basal cell carcinoma (BCC), a common and sometimes metastatic skin cancer.  Dr. Sauder provides an update on skin cancer statistics in Canada, the science behind primary and metastatic BCC diagnosis and treatment, and shares his key insights into what the landscape of metastatic BCC immuno-oncology treatment looks like for the near future in Canada.

Missed the webinar? Listen to a recording of the presentation here

Melanoma Treatment FAQs – Do’s, Don’ts, and Managing Side Effects

Wednesday, August 5, 2020  –  7pm EDT / 4pm PDT

Join us to hear the latest updates on current immunotherapy and targeted therapy treatments for melanoma and non-melanoma skin cancers in Canada.

Dr. Smylie and Dr. Iafolla will hold a panel discussion on recommended dietary and lifestyle habits while on treatment, as well as managing toxicities from fever and pneumonitis to dermatologic complications from immune checkpoint inhibitors.

Missed the webinar? Listen to a recording of the presentation here

Management of Melanoma Treatment in the COVID-19 Setting

Tues, June 23, 2020 | 7pm EDT / 4pm PDT

Hear Presenters Nicole Look Hong, MD, M.Sc., Surgeon, Sunnybrook Health Sciences Centre, Marcus Butler, MD, Medical Oncology, Princess Margaret Cancer Centre, and Massey Nematollahi, Immuno-Oncology Clinical Nurse Specialist, William Osler Health System, as they discuss how the COVID-19 pandemic has affected melanoma treatment and care in their Centres.  Dialogue will continue with focus on treatment side effects, the common side effects of targeted therapy and immunotherapies in melanoma, how these side effects may overlap with COVID-19 symptoms, what to watch for and how to effectively manage key common side effects of these therapies.

Missed the webinar? Listen to a recording of the presentation here

Merkel Cell Carcinoma: From Diagnosis to Treatment

Wednesday, November 27, 2019  1pm EST | 10am PST

Dr. Marco Iafolla, Medical Oncologist at William Osler Health System, reviews the latest news, clinical data and other updates as they relate to the treatment of merkel cell carcinoma (MCC), a rare yet aggressive non-melanoma skin cancer. MCC can develop in the merkel cells, which are found in the deepest areas of the epidermis and hair follicles. Merkel cell carcinoma can metastasize, or spread, to other parts of the body, making it metastatic MCC.  Dr. Iafolla provides an update on the science behind primary and metastatic MCC diagnosis, an overview of the disease features, staging and prognostication, surgery and treatment options including immuno-oncology for MCC, and the impact of all of this to patients.

Missed the webinar? Listen to a recording of the presentation here

Squamous Cell Carcinoma: What Patients Need to Know

Thursday, September 19, 2019  7pm EST | 4pm PST

Dr. David Zloty, Dermatologist and Clinical Professor at UBC, reviews the latest news, clinical data and other updates as they relate to the treatment of cutaneous squamous cell carcinoma (cSCC), a common and sometimes metastatic skin cancer. Dr. Zloty provides an update on skin cancer statistics in Canada, an overview of the disease features, staging and prognostication, surgery and treatment options including immuno-oncology for cSCC, and the impact of all of this to patients.  Additionally, Erin Vidic, a Medical Writer with the National Comprehensive Cancer Network® (NCCN®), introduces the 2019 Patient Guidelines for Squamous Cell Skin Cancer. This comprehensive resource gives skin cancer patients a reliable checklist to inform decisions in their care, which is much-needed for this common form of cancer, and even more helpful in the metastatic setting.

Missed the webinar? Listen to a recording of the presentation here

Ocular Melanoma: Innovative Treatments and Beyond

Friday, February 15, 2019  10am EST | 7am PST

With Dr. Marcus Butler, Princess Margaret Cancer Centre, Toronto, Canada   AND   Dr. Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, California

This webinar provides an update on the landscape of metastatic ocular melanoma treatment in Canada and the United States. Dr. Hamid and Dr. Butler will share their knowledge of current practices and care pathways, identifying the most pressing needs for patients.  They also discuss new and immerging treatment options such as IMCgp100, as well as clinical trials available to Canadian patients with ocular or uveal melanoma. Nigel Deacon, metastatic ocular melanoma survivor and patient advocate, will share his experience with this rare cancer; Kathy Barnard will facilitate the discussion.

Missed the webinar? Listen to a recording of the presentation here

Treatment Options for Melanoma Patients in the Adjuvant Setting

Tuesday, November 20, 2018  1pm EST | 10am PST

Dr. Joel Claveau, Medical Oncologist, reviews the latest news, clinical data and other updates as they relate to melanoma treatment in the adjuvant setting, presented this year in the conference season.  Dr. Claveau will share his key insights into what the landscape of adjuvant melanoma immuno-oncology treatment looks like for the near future in Canada. Additionally, Dr. Adrian Gunaratne, Medical Science Liaison with Novartis, will detail the science behind targeted therapy and what is coming for Canadian melanoma patients in the adjuvant setting with a BRAF positive mutation.

Facilitated by Kathy Barnard of Save Your Skin Foundation, the discussion continues with a patient and a caregiver both having had treatment access challenges in the adjuvant melanoma setting, and how their experience impacted their lives and that of their families.

Missed the webinar? Listen to a recording of the presentation here

Navigating Clinical Trials and Melanoma Treatment Pathways in Canada

Thursday, August 9, 2018  1pm EST | 10am PST

Join us for an informative discussion with three leading melanoma oncologists as they help us understand the current landscape of melanoma treatment and clinical trials in Canada.  They will discuss how their research impacts access to trials, how patients can best stay informed about options to participate in clinical trials, where to find trials, how to get into them, and how to stay informed of the outcomes. Presenters: Dr. Marcus Butler, Princess Margaret Cancer Centre, Toronto, Ontario,  Dr. Wilson Miller, Jewish General Hospital, Montreal, Quebec, and Dr. Michael Smylie, Cross Cancer Institute, Edmonton, Alberta.

Missed the webinar? Listen to a recording of the presentation here

For more information about clinical trials in Canada, click here to view our page About Clinical Trials.

Mental Wellness & Support After a Cancer Diagnosis

Thursday, July 12, 2018  1pm EST | 10am PST

Hear Clinical Counsellors Danielle Schroeder and Allison Prinsen speak about the importance of having ongoing emotional and social support during and after a cancer diagnosis.  When we consider just how much is required physically, emotionally, mentally, socially, and spiritually of people living through cancer, we can better understand why people cannot do it alone and why they need the right kind of support around them to help them cope. Danielle and Allison will provide insight into some of the common challenges that affect individuals and their families, mentally and emotionally, after learning they have cancer; Fear and worry, especially how to live with the fear of recurrence, changes in relationships, identity issues, and grief and loss.  They will talk about ways to work with these difficult emotions, and how to feel less isolated when experiencing them.

Missed the webinar? Listen to a recording of the presentation here

Also available: Slide presentation by Danielle and Allison at Callanish Society, Vancouver, BC

Innovative Treatment Survivors of Melanoma

Thursday, May 24, 2018  1pm EST | 10am PST

Advancement in the treatment of cancer means that patients have a real chance at not only survival, but living and living well, without cancer. In this webinar, panelists and melanoma survivors who are recipients of innovative immunotherapy treatments redefine and reimagine life with cancer and life beyond cancer. Hear Kathy Barnard, Nigel Deacon, Meloney Edghill, and Bob and Yvonne Gerard as they share their personal stories and discuss the value that innovative medicines continue to bring to their lives.

Missed the webinar? Listen to a recording of the presentation here

About Biosimilars: What We Know and What We Want to Know

Friday, January 19, 2018  1pm EST | 10am PST

Presenters: Louise Binder, SYSF Health Policy, Cathy Parker, Director Policy and International Collaboration – Health Canada, and Helen Mai, Policy and Strategy Advisor, CADTH.  This webinar is a panel discussion on Biosimilars in oncology, the approval process and the potential policy position for oncology drug reimbursement. Discussion Points include Health Canada’s review and approval for sale, CADTH’S role in this area and their involvement with pCPA, and potential policy objectives and position for oncology drug reimbursement.

Missed the webinar? Listen to a recording of the presentation here or view the presentations via SlideShare, here.

Also please click here for a page of Resources regarding Biosimilars.

Health Technology Assessment: What does value really mean for public drug plans?

Wednesday, November 1, 2017 | 12pm EDT

Presented by Matthew Brougham, this webinar will describe the process used by nine provinces and the territories to assess the value of a drug in determining whether public drugs plans should reimburse the drug through their plans. This is called a health technology assessment. It will describe the role and methodology of the Canadian Agency for Drugs and Technologies in Health in leading this assessment for both oncology and non-oncology drugs.

Missed the webinar? Listen to a recording of the presentation here

pan-Canadian Public Health Systems: the Basics

Wednesday, October 18, 2017 | 12pm EDT

Presented by Wayne Critchley and Louise Binder. This webinar will provide a broad conceptual blueprint of federal and provincial/territorial public health policy structures across Canada, describing the legal framework, government responsibility centres and their mandates for treatment access, with reference to specific opportunities for patient engagement. This is a primer for attendees attending the November 15-16, 2017 Drug Pricing Policy Summit and for others who would like to have a review of these systems for their interest.

Missed the webinar? Listen to a recording of the presentation here

Post-ASCO Webinar

Thursday, June 22, 2017 | 4:30pm PST | 7:30pm EST

Presented by Dr. Omid Hamid, Director of the Melanoma Center at The Angeles Clinic and Research Institute, this webinar reviews late breaking news, key takeaways, clinical data and other updates presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting that took place in June 2017 in Chicago, Illinois.  Dr. Hamid will share his key insights into what the landscape of melanoma treatment looks like for the near future.  As Director of the Melanoma Center at The Angeles Clinic and Research Institute, Dr. Omid Hamid works to ensure that patients receive access to the most up-to-date therapeutics, based on molecular pathways of melanoma progression.

Missed the webinar? Listen to a recording of the presentation here

Skin Cancer Awareness

Tuesday, June 20, 2017 | 3pm PST | 6pm EST

Presented by Dr. Joël Claveau, Dermatologist, Ville de Québec, Quebec, this webinar will discuss the different types of skin cancer, sun safety practices and the importance of early detection. Dr. Claveau specializes in skin cancer, particularly melanoma. He is a leading authority in his field and regularly participates in medical conferences to share his expertise with colleagues.

Missed the webinar? Listen to a recording of the presentation here

Living Beyond Cancer

Thursday, May 25, 2017 at 9am PST | 12pm EST

Advances in the treatment of cancer and especially melanoma means that patients have a real chance at not only survival but living and living well without cancer. In this webinar, panelists and melanoma survivors redefine and reimagine life with cancer and life beyond cancer. Join Kathy Barnard, Lyall Woznesensky, Shannon Gaudette and Chris Brochu as they share their personal stories and help other patients through and beyond their cancer experience.

Missed the webinar? Listen to a recording of the presentation here

A Global Perspective on the Changing Face of Cancer

Thursday, March 13, 2017 at 8am PST | 11am EST

With Dr. Jason Luke from Chicago, USA, and Dr. Marcus Butler from Toronto, Canada 

This webinar explores the evolution of cancer treatments and the cancer patient, how new innovations in cancer care and personalized treatment have changed quality of life and side effects for patients, and will provide an international lens on how scientists and researchers are harnessing these new innovations to find a cure.

Missed the webinar? Listen to a recording of the presentation here

Current Melanoma Treatments in Canada: What Patients Need to Know

Thursday, March 9, 2017 at 2pm EST | 12pm MDT | 11am PST

With Dr. Wilson Miller, Professor in the Departments of Oncology and Medicine, McGill University and Director of the Clinical Research Unit at the Jewish General Hospital

This webinar is intended to educate patients on the current landscape of melanoma treatments in Canada, which treatment options are on the horizon, and the clinical trials for melanoma currently underway in Quebec.

Missed the webinar? Listen to a recording of the presentation here

Clinical Trials: What Patients Need to Know

Thursday, February 9, 2017 at 2pm EST | 12pm MDT | 11am PST

With Dr. Natasha Kekre, Associate Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute

This webinar is to educate patients about clinical trials: where to find information about them, what their purpose is, how they work, who is eligible, and why one should participate.  This webinar discusses the important position clinical trials hold in the treatment of cancers and other illnesses and provide the patient with information regarding the process of finding and participating in clinical trials, their eligibility for clinical trials, and any other questions they might have.

Missed the webinar? Listen to a recording of the presentation here

Patients now also have access to a digital cancer registry where they can get information on what trials are being conducted and where, click here to learn more.

Understanding your Pathology Report

Thursday, October 13, 2016 at 12pm EDT | 10am MDT | 9am PDT

With Dr. Alan Spatz, MD  Director, Pathology Department, Jewish General Hospital & Professor, Pathology and Oncology, McGill University
To diagnose diseases such as cancer, a sample of tissue called a biopsy is taken from a patient and examined by a pathologist to determine if cancer is present. A pathologist will then examine specimens removed during surgery (resections) for conditions such as cancer, to determine whether the tumour is benign or cancerous, and if cancerous, the exact cell type, grade and stage of the tumour. The pathologist, who is a member of your medical team, writes the pathology report that your treating doctor uses to provide the best care for you as a patient. In this webinar, Dr. Alan Spatz provides insight on understanding your pathology report so that you can play an active role in your treatment.

Missed the webinar? Listen to a recording of the presentation here

Post-ASCO Webinar with Dr. Omid Hamid

Friday, August 26, 2016 at 4pm PDT | 5pm MDT | 7pm EDT

With Dr. Omid Hamid, Director of the Melanoma Center at The Angeles Clinic and Research Institute

This webinar reviews late breaking news, key takeaways, clinical data and other updates presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting that took place in June 2016 in Chicago, Illinois.  Dr. Hamid will share his key insights into what the landscape of melanoma treatment looks like for the near future.  As the  Director of the Melanoma Center at The Angeles Clinic and Research Institute, Dr. Omid Hamid works to ensure that patients receive access to the most up-to-date therapeutics, based on molecular pathways of melanoma progression.  Most recently, in his role with the Phase 1 Developmental Therapeutics Program, Dr. Hamid has been instrumental in bringing new therapies from the investigational lab to the clinic for patient benefit.  These therapies involve immunological therapies such as PD-1 inhibitors, therapies against tumor angiogenesis, and targeted agents that block internal processes in tumor cell’s function.

Missed the webinar? Listen to a recording of the presentation here

The Pharmacoeconomics of Cancer Drugs

Friday, February 26, 2016 at 12pm EST | 10am MST | 9am PST

With Frédéric Lavoie, Professor of Economics at Université de Montreal and Head, Oncology Policy and Reimbursement at Novartis Canada

With new breakthroughs in cancer care and the subsequent rise in costs for these treatments, health economics is playing an increasingly important role in health care. What is pharmacoeconomics and what role does it play in the Canadian Health Care System and in the reimbursement decision-making process? This webinar provides a greater understanding of what pharmacoeconomics is from a Canadian perspective and what this means for the cancer patient.

Missed the webinar? Listen to a recording of the presentation here

Melanoma: A Year at a Glance

Friday, January 29, 2016 at  7am EST | 4am PST | 2pm CET

This webinar facilitates an open discussion with oncologists on what was new in melanoma treatment options in 2015 and what we hope to see in 2016. The panel will bring together Dr. Omid Hamid, Director of the Melanoma Center at The Angeles Clinic and Research Institute; Dr. Reinhard Dummer, Vice-Chairman of the Department of Dermatology and Head of the Skin Cancer Unit at the University Hospital of Zürich; and Dr. Wilson Miller, Professor of Departments of Oncology and Medicine, McGill University and Director of the Clinical Research Unit at the Jewish General Hospital in Montreal, Quebec.

Missed the webinar? Listen to a recording of the presentation here

Post-SMR Webinar

Thursday, January 14, 2016 at 12pm EST | 10am MST | 9am PST

The first medical webinar in our new “Spotlight on Skin Cancer” series, will be a Post-Society for Melanoma Research Conference with Dr. Winson Y. Cheung, Medical Oncologist at the British Columbia Cancer Agency. Dr. Cheung will share updates and key findings presented at the 2015 Society for Melanoma Conference in San Francisco, California.  As well as the information provided, participants will have the opportunity to discuss key takeaways, late breaking news and clinical data with colleagues from across Canada.

Missed the webinar? Listen to a recording of the presentation here

The Drug Evaluation Process: Patient Input Submissions and Responsible Advocacy for New Treatment

Thursday, December 17, 2015 at 2am EST | 12pm MST | 11am PST

With Bill Dempster from 3Sixty Public Affairs

This webinar discusses the process used to evaluate drugs, concluding with recommendations about whether they should be covered by provincial formularies. In particular, this webinar will look at how patients can engage in the process.  The presentation addresses the following topics:

When and how can patients engage with the drug evaluation process?
What are the best practices to promote the patient’s voice?
Looking ahead: how can we improve patients’ opportunities to engage?

Missed the webinar? Listen to a recording of the presentation here

Canadian Cancer Therapy Approval, Evaluation and Funding Process: What is the Role of the Patient?

Tuesday, December 8, 2015 at 2am EST | 12pm MST | 11am PST

With Gerry Jeffcott and Bill Dempster from 3Sixty Public Affairs

This webinar provides insight into how cancer drugs are reviewed by Health Canada, through the multi-step decision-making process that determines whether they are covered by public and private formularies.  The presentation will address the following topics:
What are the different steps to bring a new cancer drug to patients?
Where can patients make a difference?
How is the patient role changing?

Missed the webinar? Listen to a recording of the presentation here

Surviving Melanoma: A Discussion on Survivorship

Thursday, April 30th 2015 at 9:45 AM PST

With Kathy Barnard, Nigel Deacon, Terry Jaillet, Natalie Richardson

Life after cancer can be anything but ordinary. Join Kathy Barnard, President and Founder of the Save Your Skin Foundation, along with a panel of survivors from across Canada as they discuss their personal stories, struggles, triumphs, what survivorship means and how they got there. Melanoma month kicks off with this webinar to inspired hope that surviving cancer is possible, whether you have melanoma or another form of cancer.

Missed the webinar? Listen to a recording of the presentation here

Are you Ready for your Meeting with your Oncologist?

Wednesday, March 18th, 2015 at 10 AM PST

With Laura Wilson, Symptoms Management and Drug Access Nurse- Lions Gate Hospital, North Vancouver

In this webinar, Laura Wilson discusses the important factors to consider before meeting your Oncologist so that you can ask the right questions to make informed decisions and be an active participant in your cancer care.

Questions asked after the webinar include: At which point should an Oncologist be part of my team if I am diagnosed with stage 1 or 2 (or maybe 3) melanoma? Should I be seeing an Oncologist even if I had my melanoma surgically removed by my Dermatologist?

Laura Wilson’s answer: It never hurts to be referred, it is probably less important for a stage 1 but is definitely important for a stage 2 or 3.

Missed the webinar? Listen to a recording of the presentation here

View the slides from this presentation on slideshare here.

Le Cancer de la Peau au Quebec (French)

Friday, February 27, 2015 at 10am PST

With Dr. Claveau, Dermato-Oncologist- Hopital Dieu de Quebéc, Quebéc

In this webinar, Dr. Claveau prevents an overview of skin cancer in Quebéc and treatment options, with a focus on melanoma.

The Melanoma Landscape in Canada Today

Friday, February 13, 2015 at 10am PST

With Dr. Michael Smylie, Medical Oncologist- Cross Cancer Institute, Edmonton, Alberta

Over the past few years, the landscape of melanoma has changed dramatically with the arrival of new therapies. In this webinar, Dr. Smylie walks us through those changes and helps us to understand what treatment options are available today.

PATIENTS BENEFIT FROM EDUCATION INITIATIVES

Making awareness and education available is crucial. Since 2006, the Foundation has worked to raise awareness of melanoma and non-melanoma skin cancers focusing on education, prevention and the need for improved patient care.